Thepharmaletter.com

A drug company is being accused of exploiting a federal program meant to encourage research into rare diseases came, and on Monday two U.S. lawmakers started demanding answers. Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.) allege that...

— FDA approval would allow widespread access for U.S. patients with Duchenne — — Deflazacort could be among the first FDA-approved treatments for this devastating genetic disorder — Northbrook, Ill. – August 10, 2016 – Marathon Pharmaceuticals, LLC...

An important new book release from Elsevier Academic Press. Philadelphia, PA – December 5, 2016 The development process for new medicines fails at a staggering rate, placing our collective health in jeopardy.  It’s estimated that barely 0.1 percent...

On Wednesday, Shares of Qlik Technologies Inc (NASDAQ:QLIK), gained 3.29% to $36.45. As featured during the plenary session on climate and resiliency at the 2015 Clinton Global Initiative (CGI) Annual Meeting, Qlik (QLIK), a leader in visual analytics...

nursing home, healthcare providers, allied healthwith only two torpedoes. Then test it on your vision by dropping individual drop into your eye. You will feel a of a sting. Keep adding a torpedo up to the sting is not really that severe or so that it...